MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Pacific Biosciences of California Company Profile (NASDAQ:PACB)

Consensus Ratings for Pacific Biosciences of California (NASDAQ:PACB) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $11.60 (25.95% upside)

Analysts' Ratings History for Pacific Biosciences of California (NASDAQ:PACB)
Show:
DateFirmActionRatingPrice TargetActions
2/5/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016JPMorgan Chase & Co.Boost Price Target$10.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Piper JaffrayDowngradeOverweight -> Neutral$9.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Cantor FitzgeraldReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Cantor FitzgeraldBoost Price TargetBuy$11.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015JPMorgan Chase & Co.Boost Price Target$7.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015Piper JaffrayUpgradeNeutral -> Overweight$7.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2015StephensUpgradeEqual Weight -> Overweight$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2015Cantor FitzgeraldReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2015Cantor FitzgeraldReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015Maxim GroupReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/26/2015Cantor FitzgeraldInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015William BlairUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015StephensInitiated CoverageEqual Weight$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2015Maxim GroupBoost Price TargetBuy$10.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2014Deutsche BankUpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2014JPMorgan Chase & Co.UpgradeUnderweight -> Neutral$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/6/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha